CD95/CD95 Ligand (Fas/Fasl, APO‐1/APO‐1L)
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Kapitel/Artikel |
| Sprache: | Englisch |
| Veröffentlicht: |
15 January 2002
|
| In: |
Wiley encyclopedia of molecular medicine
Year: 2002, Pages: 687-692 |
| DOI: | 10.1002/0471203076.emm0412 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1002/0471203076.emm0412 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/10.1002/0471203076.emm0412 |
| Verfasserangaben: | Peter H. Krammer, Andreas Krueger |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1750214318 | ||
| 003 | DE-627 | ||
| 005 | 20220819124847.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210303s2002 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/0471203076.emm0412 |2 doi | |
| 035 | |a (DE-627)1750214318 | ||
| 035 | |a (DE-599)KXP1750214318 | ||
| 035 | |a (OCoLC)1341396892 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Krammer, Peter H. |d 1946- |e VerfasserIn |0 (DE-588)121766373 |0 (DE-627)081520255 |0 (DE-576)292873417 |4 aut | |
| 245 | 1 | 0 | |a CD95/CD95 Ligand (Fas/Fasl, APO‐1/APO‐1L) |c Peter H. Krammer, Andreas Krueger |
| 264 | 1 | |c 15 January 2002 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.03.2021 | ||
| 700 | 1 | |a Krueger, Andreas |d 1973- |e VerfasserIn |0 (DE-588)124334539 |0 (DE-627)08579371X |0 (DE-576)294124802 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Wiley encyclopedia of molecular medicine |d New York : John Wiley, 2002 |g (2002), Seite 687-692 |h Online-Ressource (5 v) |w (DE-627)096445939 |w (DE-576)9096445937 |z 1591245249 |7 nnam |a CD95/CD95 Ligand (Fas/Fasl, APO‐1/APO‐1L) |
| 773 | 1 | 8 | |g year:2002 |g pages:687-692 |g extent:6 |a CD95/CD95 Ligand (Fas/Fasl, APO‐1/APO‐1L) |
| 856 | 4 | 0 | |u https://doi.org/10.1002/0471203076.emm0412 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/10.1002/0471203076.emm0412 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210303 | ||
| 993 | |a BookComponentPart | ||
| 994 | |a 2002 | ||
| 998 | |g 121766373 |a Krammer, Peter H. |m 121766373:Krammer, Peter H. |d 50000 |e 50000PK121766373 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1750214318 |e 3880731497 | ||
| BIB | |a Y | ||
| JSO | |a {"name":{"displayForm":["Peter H. Krammer, Andreas Krueger"]},"recId":"1750214318","id":{"eki":["1750214318"],"doi":["10.1002/0471203076.emm0412"]},"title":[{"title_sort":"CD95/CD95 Ligand (Fas/Fasl, APO‐1/APO‐1L)","title":"CD95/CD95 Ligand (Fas/Fasl, APO‐1/APO‐1L)"}],"person":[{"roleDisplay":"VerfasserIn","given":"Peter H.","display":"Krammer, Peter H.","family":"Krammer","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Andreas","display":"Krueger, Andreas","family":"Krueger"}],"type":{"media":"Online-Ressource","bibl":"chapter"},"origin":[{"dateIssuedKey":"2002","dateIssuedDisp":"15 January 2002"}],"language":["eng"],"note":["Gesehen am 03.03.2021"],"physDesc":[{"extent":"6 S."}],"relHost":[{"type":{"bibl":"edited-book","media":"Online-Ressource"},"person":[{"family":"Kazazian","roleDisplay":"Hrsg.","given":"Haig Hagop","display":"Kazazian, Haig Hagop","role":"edt"}],"part":{"year":"2002","pages":"687-692","text":"(2002), Seite 687-692","extent":"6"},"titleAlt":[{"title":"Encyclopedia of molecular medicine"},{"title":"Molecular medicine"}],"title":[{"title_sort":"Wiley encyclopedia of molecular medicine","title":"Wiley encyclopedia of molecular medicine"}],"id":{"eki":["096445939"],"isbn":["1591245249"]},"recId":"096445939","name":{"displayForm":["editorial board, Haig H. Kazazian, Jr. ... [et al.]"]},"note":["\"Wiley-Interscience publication.\"","Includes bibliographical references and indexes","Electronic reproduction, Norwich, N.Y : Knovel, 2003"],"physDesc":[{"extent":"Online-Ressource (5 v)"}],"disp":"CD95/CD95 Ligand (Fas/Fasl, APO‐1/APO‐1L)Wiley encyclopedia of molecular medicine","language":["eng"],"origin":[{"publisher":"John Wiley","dateIssuedDisp":"c2002","publisherPlace":"New York","dateIssuedKey":"2002"}]}]} | ||
| SRT | |a KRAMMERPETCD95CD95LI1520 | ||